Injective's native token integration on Coinbase has strengthened the project's U.S. accessibility and pushed INJ toward a critical $8 breakout level.
Injective's native token integration on Coinbase has strengthened the project's U.S. accessibility and pushed INJ toward a critical $8 breakout level.

Injective's native token integration on Coinbase has strengthened the project's U.S. accessibility and pushed INJ toward a critical $8 breakout level.
Injective's INJ token rose after Coinbase began supporting native deposits and withdrawals directly through the Injective blockchain, following the completion of the token's migration from Ethereum's ERC-20 standard to the native Injective EVM on July 22.
"The Coinbase integration removes a key friction point for U.S. investors looking to access the Injective ecosystem directly," Jason Wu, on-chain analyst at Edgen, said. "Native support means users no longer need bridge-dependent transfers, which historically created liquidity fragmentation."
INJ has been forming higher lows since finding support in the $3.50 to $4.50 demand zone, with the token now testing the $7.70 to $8.00 resistance range, according to CoinGecko data. The migration, which Coinbase supported as a 1:1 token conversion, re-enabled deposits on the exchange after a brief suspension during the swap process.
A decisive breakout above $8 would invalidate the broader lower-high structure that has defined INJ's correction in recent months and could open the path toward the $10 to $12 range, per technical analysis. On the downside, failure to hold the ascending trendline could send the token back toward $4.50 support, with the broader demand zone near $3.50 as the next line of defense.
Coinbase Integration Expands Injective's Reach
The native INJ support on Coinbase marks a milestone for Injective's growth strategy. As one of the largest regulated cryptocurrency exchanges in the U.S., Coinbase provides exposure to millions of retail and institutional investors. Greater accessibility could translate into stronger ecosystem participation, particularly as decentralized finance activity expands across Layer-1 networks.
Injective has steadily expanded its infrastructure across decentralized exchanges, real-world asset initiatives, tokenized finance, and AI-powered applications. The network, built on the Cosmos SDK, offers cross-chain trading capabilities with gas-free transactions, according to the project's documentation. Easier access through Coinbase may encourage additional liquidity and user participation, both of which are important for sustaining long-term growth.
What's at Stake for INJ Holders
The $7.70 to $8.00 zone represents the biggest technical challenge for the current recovery. Previous selling pressure created a significant supply cluster in this region, and buyers will need to absorb that overhead to confirm a trend reversal. If INJ clears that level, the next major target sits in the $10 to $12 range, representing potential upside of more than 50% from current levels.
On the fundamental side, the Coinbase integration strengthens one of the market's key investment narratives: blockchain networks that improve accessibility while expanding utility often attract stronger investor attention during broader market recoveries. The token migration to native Injective EVM also aligns with the network's goal of reducing reliance on Ethereum infrastructure and building independent DeFi capabilities.
This article is for informational purposes only and does not constitute investment advice.